Hjem
Alfred Halstensens bilde

Alfred Halstensen

Professor
  • E-postAlfred.Halstensen@uib.no
  • Telefon+47 55 97 30 70+47 932 19 980
  • Besøksadresse
    Haukeland universitetssykehus, Laboratoriebygget
  • Postadresse
    Postboks 7804
    5020 Bergen
Vitenskapelig artikkel
  • Vis forfatter(e) (2020). Effect of cod residual protein supplementation on markers of glucose regulation in lean adults: A randomized double-blind study. Nutrients. 1-12.
  • Vis forfatter(e) (2019). Cod protein powder lowered serum nonesterified fatty acids and increased total bile acid concentrations in healthy, lean, physically active adults: A randomized double-blind study. Food & Nutrition Research. 9 sider.
  • Vis forfatter(e) (2018). Daily intake of protein from cod residual material lowers serum concentrations of nonesterified fatty acids in overweight healthy adults: A randomized double-blind pilot study. Marine Drugs. 1-15.
  • Vis forfatter(e) (2018). Cod Residual Protein Prevented Blood Pressure Increase in Zucker fa/fa Rats, Possibly by Inhibiting Activities of Angiotensin-Converting Enzyme and Renin. Nutrients. 1820.
  • Vis forfatter(e) (2017). High intake of fatty fish, but not of lean fish, improved postprandial glucose regulation and increased the n-3 PUFA content in the leucocyte membrane in healthy overweight adults: A randomised trial. British Journal of Nutrition. 1368-1378.
  • Vis forfatter(e) (2013). Meningococcal Omp85 in detergent-extracted outer membrane vesicle vaccines induces high levels of non-functional antibodies in mice. Scandinavian Journal of Immunology. 452-459.
  • Vis forfatter(e) (2011). Pandemic influenza vaccination of hypogammaglobulinemic patients induces normal or elevated influenza-specific CD4+Th1-cell responses. Influenza and Other Respiratory Viruses. 376-379.
  • Vis forfatter(e) (2011). Pandemic Influenza Vaccination Elicits Influenza-Specific CD4(+) Th1-cell Responses in Hypogammaglobulinaemic Patients: Four case reports. Scandinavian Journal of Immunology. 210-218.
  • Vis forfatter(e) (2006). Variations in case fatality and fatality risk factors of meningococcal disease in Western Norway, 1985-2002. Epidemiology and Infection. 103-110.
  • Vis forfatter(e) (2006). High case-fatality rates of meningococcal disease in Western Norway caused by serogroup C strains belonging to both sequence type (ST)-32 and ST-11 complexes, 1985-2002. Epidemiology and Infection. 1195-1202.
  • Vis forfatter(e) (2003). FcgammaRIIa and FcgammaRIIIb polymorphisms were not associated with meningococcal disease in Western Norway. Epidemiology and Infection. 193-199.
  • Vis forfatter(e) (2001). Infeksjoner med gruppe A-streptokokker i hud, bløtdeler og blod. Tidsskrift for Den norske legeforening. 3310-3314.
  • Vis forfatter(e) (2000). Phagocytosis: measurement by flow cytometry. JIM - Journal of Immunological Methods. 229-242.
  • Vis forfatter(e) (2000). Phagocytosis: measurement by flow cytometry. JIM - Journal of Immunological Methods. 229-242.
  • Vis forfatter(e) (2000). Patterns of cell death induced by eluates of denture base acrylic resins in U-937 human monoblastoid cells. European Journal of Oral Sciences. 59-69.
  • Vis forfatter(e) (2000). Patterns of cell death induced by eluates from denture base acrylic resins in U-937 human monoblastoid cells. European Journal of Oral Sciences. 59-69.
  • Vis forfatter(e) (2000). Patterns of cell death induced by eluates from denture base acrylic resins in U-937 human monoblastoid cells. European Journal of Oral Sciences. 59-69.
  • Vis forfatter(e) (2000). Eradication of non-typhoid salmonellae in acute enteritis after therapy with ofloxacin for 5 or 10 days. Journal of Antimicrobial Chemotherapy. 457-459.
  • Vis forfatter(e) (2000). Concurrent measurement of antigen- and antibody dependent oxidative burst and phagocytosis in monocytes and neutrophils. Meth Enzymol. 203-220.
  • Vis forfatter(e) (2000). Concurrent measurement of antigen- and antibody dependent oxidative burst and phagocytosis in monocytes and neutrophils. Methods Enzymol. 203-220.
  • Vis forfatter(e) (1999). Outbreak of meningococcal disease in western Norway due to a new serogroup C variant of the ET-5 clone: effect of vaccination and selective carriage eradication. Epidemiology and Infection. 373-382.
  • Vis forfatter(e) (1999). Human opsonins induced during meningococcal disease recognize outer membrane proteins PorA and PorB. Infection and Immunity. 2552-2560.
  • Vis forfatter(e) (1999). Human opsonins induced during mengococcal disease recognize transferrin binding protein complexes. Infection and Immunity. 6526-6532.
  • Vis forfatter(e) (1999). Human opsonins induced during mengococcal disease recognise outer membrane proteins PorA and PorB. Infection and Immunity. 2552-2560.
  • Vis forfatter(e) (1999). Functional differentiation of acute myeloid leukaemia blast cells. APMIS - Journal of Pathologiy, Microbiology and Immunology. 1023-1033.
  • Vis forfatter(e) (1998). Flow cytometric quantitation of human opsonin-dependent phagocytosis and oxidative burst responses to meningococcal antigens. Cytometry. 406-413.
  • Vis forfatter(e) (1998). Effect of aluminium hydroxide and meningococcal serogroup C capsular polysaccharide on the immynogenisity og a group B Neisseria meningitidis outer mebrane vesicle vaccine. Developments in Biologicals. 323-333.
  • Vis forfatter(e) (1998). Effect of aluminium hydroxide and meningococcal serogroup C capsular polysaccharide on the immunogenicity and reactogenicity of a group B Neisseria meningitidis outer membrane vesicle vaccine. Developments in Biologicals. 323-333.
  • Vis forfatter(e) (1998). Effect of aluminium hydroxide adjuvant and serogroup C polysaccharide on the immunogenicity and reactogenicity of a group B Neisseria meningitidis outer membrane vesicle vaccine. Developments in Biologicals. 323-333.
  • Vis forfatter(e) (1997). Interleukin 4 responses in acute leukemia patients with severe chemotherapy-induced leucopenia. European Journal of Haematology. 269-276.
  • Vis forfatter(e) (1997). Interleukin 4 responses in acute leukaemia patients with severe chemotherapy-induced leucopenia. European Journal of Haematology. 269-276.
  • Vis forfatter(e) (1997). Functional assays for evaluation of serogroup B meningococcal structures as mediators of human opsonophagocytosis. JIM - Journal of Immunological Methods. 55-68.
  • Vis forfatter(e) (1996). The role of cytokines in the pathogenesis of Neisseria meningitidis infection. Current Opinion in Infectious Diseases. 146-149.
  • Vis forfatter(e) (1996). Serum Levels of Adhesion Molecules and Cytokines in Patients with Acute Leukaemia. Leukemia and Lymphoma. 423-450.
  • Vis forfatter(e) (1996). Endotoxin and cytokines in plasma and clinical manifestations during treatment of septicaemia with imipenem or cefuroxime/metronidazole. Immunology & Infectious Diseases. 159-166.
  • Vis forfatter(e) (1996). Endotoxin and cytokines in plasma and clinical manifestations during treatment of septicaemia with Imipenem or Cefuroxime/Metronidazole. Immunology & Infectious Diseases. 159-166.
  • Vis forfatter(e) (1996). Endotoxin and cytokines in plasma and clinical evaluation during treatment of septicemia with imipenem or cefuroxim/metronidazol. Immunology & Infectious Diseases.
  • Vis forfatter(e) (1995). Strain differentiation of Neisseria meningitidis by small-fragment restriction endonuclease analysis (SF-REA). APMIS - Journal of Pathologiy, Microbiology and Immunology. 147-153.
  • Vis forfatter(e) (1995). Strain differentiation of Neisseria meningitidis by small fragment res triction endonuclease analysis. APMIS - Journal of Pathologiy, Microbiology and Immunology. 147-153.
  • Vis forfatter(e) (1995). Small-fragment restriction endonuclease analysis of Neisseria meningitidis carrier strains. APMIS - Journal of Pathologiy, Microbiology and Immunology.
  • Vis forfatter(e) (1995). Single dose oflozacin to eradicate pharyngeal carriage of Neisseria me ningitidis. Drugs. 399-400.
  • Vis forfatter(e) (1995). Single dose ofloxacin to eradicate pharyngeal carriage of Neisseria meningitidis. Drugs. 399-400.
  • Vis forfatter(e) (1995). High levels of Interleukin 10 in serum are associated with fatality in meningococcal disease. Infection and Immunity. 2109-2112.
  • Vis forfatter(e) (1995). Double-blind comparison of ofloxacin for 3 days and placebo in acute bacterial enteritis. Drugs. 454-456.
  • Vis forfatter(e) (1995). Double blind comparison of ofloxacin for 3 days and placebo in acute bacterial enteritis. Drugs. 454-456.
  • Vis forfatter(e) (1995). Clonal diversity of Neisseria meningitidis carrier strains. APMIS - Journal of Pathologiy, Microbiology and Immunology. 147-153.
  • Vis forfatter(e) (1994). Sequele one year after meningococcal disease. Acta Neurologica Scandinavica. 139-142.
  • Vis forfatter(e) (1994). Sequelae one year after meningococcal disease. Acta Neurologica Scandinavica. 139-142.
  • Vis forfatter(e) (1994). Sequelae one year after meningococcal disease. Acta Neurologica Scandinavica. 139-162.
  • Vis forfatter(e) (1994). Necrotizing fasciitis due to group A streptococci in western Norway: Incidence and clinical features. The Lancet. 1111-1115.
  • Vis forfatter(e) (1994). Necrotising fasciitis due to group A streptococci in western Norway: incidence and clinical features. The Lancet. 1111-1115.
  • Vis forfatter(e) (1994). Necrotising fasciitis due to group A streptococci in Western Norway: incidence and clinical features. The Lancet. 1111-1115.
  • Vis forfatter(e) (1994). Mixed bacteremia with Vibrio metschnikovii in an 83-year-old female patient. Scandinavian Journal of Infectious Diseases. 493-494.
  • Vis forfatter(e) (1994). Mixed bacteremia with Vibrio metschnikovii in an 83-year-old female patient. Scandinavian Journal of Infectious Diseases. 493-494.
  • Vis forfatter(e) (1994). Mixed bacteremia with Vibrio metschnikovii in an 83-year-old female patient. Scandinavian Journal of Infectious Diseases. 493-494.
  • Vis forfatter(e) (1994). Cytokines in meningococcal disease. Baillière's Clinical Infectious Diseases. 97-108.
  • Vis forfatter(e) (1993). Use of single-dose ofloxacin to eradicate tonsillo-pharyngeal carriage of Neisseria meningitidis. Antimicrobial Agents and Chemotherapy. 2024-2026.
  • Vis forfatter(e) (1993). Single-dose ofloxacin to eradicate tonsillopharyngeal carriage of Neisseria meningitidis. Antimicrobial Agents and Chemotherapy. 2024-2026.
  • Vis forfatter(e) (1993). Interleukin-8 in serum and cerebrospinal fluid from patients with meningococcal disease. Journal of Infectious Diseases. 471-475.
  • Vis forfatter(e) (1993). Crossreacting serum opsonins to meningococci after vaccination. Journal of Infectious Diseases. 1314-1319.
  • Vis forfatter(e) (1993). Cross-reacting serum opsonins to meningococci after vaccination. Journal of Infectious Diseases. 1314-1319.
  • Vis forfatter(e) (1993). Compartmentalization of the TNF and IL-6 in meningitis and septic shock. Mediators of Inflammation. 23-25.
  • Vis forfatter(e) (1992). Spectrum of disease in bacteremic patients during a streptococcus pyogenes serotype M-1 epidemic in Norway 1988. European Journal of Clinical Microbiology and Infectious Diseases. 416-425.
  • Vis forfatter(e) (1992). Monocyte phagocytosis of opsonized neisseria meningtides serogroup B. APMIS - Journal of Pathologiy, Microbiology and Immunology. 209-220.
  • Vis forfatter(e) (1992). Monocyte phagocytosis of opsonized Neisseria meningitidis serogroup B. APMIS - Journal of Pathologiy, Microbiology and Immunology. 209-220.
  • Vis forfatter(e) (1992). Monocyte phagocytosis of opsonized Neisseria meningitidis serogroup B. APMIS - Journal of Pathologiy, Microbiology and Immunology. 209-220.
  • Vis forfatter(e) (1992). Molecular mechanisms in the compartmentalized inflammatory response presenting as meningococcal meningitis or septic shock. Microbial Pathogenesis. 423-431.
  • Vis forfatter(e) (1992). Epidemilogical studies of antimeningococcal IgM and IgG serum antibodies by an enzyme linked immunosorbent assay (ELISA) using whole bacterium as antigen. Scandinavian Journal of Infectious Diseases. 47-55.
  • Vis forfatter(e) (1992). Crossreacting serum opsonins in patients with meningococcal disease. Infection and Immunity. 2777-2783.
  • Vis forfatter(e) (1992). Cross-reacting serum opsonins in patients with meningococcal disease. Infection and Immunity. 2777-2783.
  • Vis forfatter(e) (1991). Serum opsonins to serogroup B meningococci after vaccination. NIPH Annals. 107-167.
  • Vis forfatter(e) (1991). Opsonin response in vaccinees as measured by chemiluminesence. APMIS - Journal of Pathologiy, Microbiology and Immunology. 769-772.
  • Vis forfatter(e) (1991). Immunization against serogroup B meningococci. Opsonin response in vaccinees as measured by chemiluminescence. APMIS - Journal of Pathologiy, Microbiology and Immunology. 769-772.
  • Vis forfatter(e) (1991). Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway. The Lancet. 1093-1096.
  • Vis forfatter(e) (1991). Diagnosis of systemic meningococcal disease. NIPH Annals. 107-123.
  • Vis forfatter(e) (1991). Current understanding of the pathogenesis of gram negative shock. Infectious Disease Clinics of North America. 781-791.
Rapport
  • Vis forfatter(e) (1993). Alvorlige streptokokk gruppe A bakterimier vinteren 1992-93. .
Populærvitenskapelig foredrag
  • Vis forfatter(e) (1996). Ny metode for utvelgelse av opsonininduserende meningokokkantigener.
  • Vis forfatter(e) (1996). Gamle bakterier i endret drakt.
  • Vis forfatter(e) (1994). Uspesifikt forsvar mot mikroorganismer.
  • Vis forfatter(e) (1994). Strategi og behandling av sepsis.
  • Vis forfatter(e) (1994). Septikemi hos den immunkompetente og hos den gravt nautropene pasient.
  • Vis forfatter(e) (1994). Pneumokokkvaksinen.
  • Vis forfatter(e) (1994). Nekrotiserende fasciitt.
  • Vis forfatter(e) (1994). Meningokokkvaksinen.
  • Vis forfatter(e) (1994). Meningokokksykdommen - farligst klokken ni om morgenen?
  • Vis forfatter(e) (1994). Meningokokkseptikemi. Nekrotiserende fasciitt.
  • Vis forfatter(e) (1994). Kvinoloner og cefalosporiner.
  • Vis forfatter(e) (1994). Introduksjon.
  • Vis forfatter(e) (1994). Infeksjonsprofylakse ved utenlandsreiser.
  • Vis forfatter(e) (1994). Infeksjonsmedisinske kasuistikker.
  • Vis forfatter(e) (1994). Infeksiøse tarmlidelser.
  • Vis forfatter(e) (1994). Immunterapeutiske muligheter ved septikemi.
  • Vis forfatter(e) (1994). Hudmanifestasjoner ved infeksjonssykdommer.
  • Vis forfatter(e) (1994). Herpes zoster og komplikasjoner.
  • Vis forfatter(e) (1994). Herpes zoster - klinikk, komplikasjoner og behandling (foredrag + gruppearbeid).
  • Vis forfatter(e) (1994). Gruppe A streptokokker: Mikrobiologi, epidemiologi og kliniske manifestasjoner.
  • Vis forfatter(e) (1994). Alvorlige infeksjoner på Vestlandet.
  • Vis forfatter(e) (1994). Alvorlige infeksjoner med gruppe A streptokokker.
  • Vis forfatter(e) (1994). Alvorlige infeksjoner med gruppe A streptokokker.
  • Vis forfatter(e) (1994). Alvorlige infeksjoner - diagnostikk og behandling før sykehusinnleggelse.
  • Vis forfatter(e) (1994). Akutt bakteriell enteritt.
Vitenskapelig foredrag
  • Vis forfatter(e) (2002). Praktisk antibiotikabruk.
  • Vis forfatter(e) (2002). Mennesket og mikroben.
  • Vis forfatter(e) (2002). Meningokokksepsis.
  • Vis forfatter(e) (2002). Menigokokksykdom.
  • Vis forfatter(e) (2002). Hvordan bruker vi pressen?
  • Vis forfatter(e) (2002). Hudmanifestasjoner ved infeksjonssykdommer.
  • Vis forfatter(e) (2002). Gastroenteritt.
  • Vis forfatter(e) (2002). Cross-reacting and cross-protective antibodies against Neisseria meningitidis and Neisseria lactamica in human postvaccination and patient sera.
  • Vis forfatter(e) (2002). CNS-infeksjoner.
  • Vis forfatter(e) (2002). Alvorlige streptokokkinfeksjoner.
  • Vis forfatter(e) (2001). Øvre urinveisinfeksjoner. Urosepsis.
  • Vis forfatter(e) (2001). The clinical picture of meningococcal disease.
  • Vis forfatter(e) (2001). Stafylokokk- og streptokokkinfeksjoner.
  • Vis forfatter(e) (2001). Reducing meningitis mortality by different information - data driven action.
  • Vis forfatter(e) (2001). Praktisk antbiotikabruk.
  • Vis forfatter(e) (2001). Opsonophagocytosis of meningococci.
  • Vis forfatter(e) (2001). Mennesket og mikroben.
  • Vis forfatter(e) (2001). Meningokokksykdommer.
  • Vis forfatter(e) (2001). Meningokokksepsis.
  • Vis forfatter(e) (2001). Meningokokk-vaksinen.
  • Vis forfatter(e) (2001). Meningitt og hjerneabscess.
  • Vis forfatter(e) (2001). Makrolider.
  • Vis forfatter(e) (2001). Infeksjoner i luftveiene.
  • Vis forfatter(e) (2001). Infeksjoner i hud/bløtdeler.
  • Vis forfatter(e) (2001). Hudmanifestasjoner ved infeksjonssykdommer.
  • Vis forfatter(e) (2001). Gastroenteritter.
  • Vis forfatter(e) (2001). Bakterielle tarminfeksjoner. Etiologi, patogenese.
  • Vis forfatter(e) (2001). Antibiotikabruk og økonomi.
  • Vis forfatter(e) (2001). Alvorlige streptokokkinfeksjoner.
  • Vis forfatter(e) (2000). Meningokokkvaksine ved reiser.
  • Vis forfatter(e) (2000). Meningokokkvaksine ved reiser.
  • Vis forfatter(e) (1998). Patient opsonins against specific meningococcal outer membrane components.
  • Vis forfatter(e) (1998). Meningococcal disease outbreak due to a new strain C:15:P1.7,16 in Western Norway, and selective carriage eradication of this strain.
  • Vis forfatter(e) (1997). Media og smittestoffer.
  • Vis forfatter(e) (1996). Opsonophagocytosis responses to meningococcal antigens adsorbed to beads.
  • Vis forfatter(e) (1996). High levels of interleukin 10 in serum are associated with fatality in meningococcal disease.
  • Vis forfatter(e) (1996). Effect of aluminium hydroxide adjuvant and serogroup C polysaccharide on the immunogenicity and reactogenicity of a group B Neisseria meningitidis outer membrane vesicle vaccine.
  • Vis forfatter(e) (1995). Clinical aspects of serious invasive group A streptococcal disease.
  • Vis forfatter(e) (1994). Single-dose ofloxacin to eradicate tonsillopharyngeal carriage of Neisseria meningitidis (poster).
  • Vis forfatter(e) (1994). Single-dose ofloxacin to eradicate pharyngeal carriage of Neisseria meningitidis (poster).
  • Vis forfatter(e) (1994). Increased incedence of necrotizing fasciitis caused by group A streptococci in Western Norway.
  • Vis forfatter(e) (1994). Double blind comparison of ofloxacin for 3 days and placebo in acute bacterial enteritis (poster).
  • Vis forfatter(e) (1994). Alvorlige gruppe A-streptokokkinfeksjoner i Norge 1993-1994.
Leserinnlegg
  • Vis forfatter(e) (2001). Kommunikasjon, kvalitet og omstilling. På Høyden ( UiBs nettavis).
Fagbok
  • Vis forfatter(e) (1994). Terapianbefalinger: Akutte luftveisinfeksjoner i primærhelsetjenesten. Statens legemiddelkontroll, Oslo.
Populærvitenskapelig artikkel
  • Vis forfatter(e) (2002). Hva skiller potensielt alvorlige akutte infeksjoner fra mer godartete: - en oppfordring til diskusjon. Legedialog. 5-8.
  • Vis forfatter(e) (2000). Piercing - fra et medisinsk synspunkt en katastrofe. Helsenytt for alle. 10-11.
  • Vis forfatter(e) (2000). Piercing - fra et medisinsk synspunkt en katastrofe. Helsenytt for alle. 10-11.
  • Vis forfatter(e) (1999). Skjær bort streptokokkene! Tidsskrift for Den norske legeforening. 2638.
  • Vis forfatter(e) (1996). Evaluering av undervisningen i indremedisin ved Universitetet i Bergen. Effekt av økning i studenttall, ny studieplan og innføring i nytt studiested. UPED-skrift. 142-161.
  • Vis forfatter(e) (1996). Evaluering av undervisningen i indremedisin ved Universitetet i Bergen. Effekt av økning i studenttall, ny studieplan og innføring i nytt studiested. UPED-skrift. 142-161.
Kronikk
  • Vis forfatter(e) (2004). Endokarditt til besvær. Tidsskrift for Den norske legeforening. 1794.
  • Vis forfatter(e) (1994). Nekrotiserende fasciitt med gruppe A streptokokker. MSIS-rapport. 9.
  • Vis forfatter(e) (1994). Alvorlige gruppe A streptokokkinfeksjoner 1993-94. MSIS-rapport. 9.
Doktorgradsavhandling
  • Vis forfatter(e) (2006). Meningococcal disease : clinical and epidemiological aspects.
  • Vis forfatter(e) (1988). Meningococcal disease : clinical and immunological studies.
Vitenskapelig Kapittel/Artikkel/Konferanseartikkel
  • Vis forfatter(e) (1999). Behandling versus ingen behandling av akutt tonsilitt. Hva gjør granulocyttene på tonsillene? 3 sider.
  • Vis forfatter(e) (1997). Effect of aluminium hydroxide adjuvant and serogroup C polysaccharide on the immunogenicity and reactogenicity of a group B <I>Neisseria meningidis</I> outer membrane vesicle vaccine. 11 sider.
  • Vis forfatter(e) (1996). High levels of interleukin 10 are associated with fatality in meningococcal disease. 3 sider.
  • Vis forfatter(e) (1994). The role of tumor necrosis factor, interleukin-1, interleukin-6 and interlaukin-8 in patients with meningococcal disease. 7 sider.
  • Vis forfatter(e) (1992). TNF in serum in patients with bacterial infections. 2 sider.
Poster
  • Vis forfatter(e) (2016). Effects of water soluble and water insoluble cod protein on lipid metabolism in overweight adults.
  • Vis forfatter(e) (2016). Effects of water soluble and water insoluble cod protein on lipid metabolism in overweight adults.
  • Vis forfatter(e) (2003). Case fatality of meningococcal disease in Western Norway, 1985-2002.
  • Vis forfatter(e) (2001). FcγRIIa and FcγRIIIb allotypes were not associated with contraction or severity of systemic meningococcal disease in Norwegian teenagers and adults.
  • Vis forfatter(e) (2000). Reduced case fatality rate of mengococcal disease after public information about the early signs of meningococcal septicemia.
  • Vis forfatter(e) (2000). Reduced case fatality rate of mengococcal disease after public information about the early signs of meningococcal septicemia.
  • Vis forfatter(e) (2000). Ofloxacin for non-typhoid salmonella enteritis.
  • Vis forfatter(e) (2000). Ofloxacin for non-typhoid salmonella enteritis.
  • Vis forfatter(e) (1996). Routine Quantitation of phagocytosis by flow cytometry.

Se fullstendig oversikt over publikasjoner i CRIStin.